Anti-inflammatory action of diltiazem in patients with unstable angina

Postgraduate Medical Journal

Volumn 82, Issue 971, 2006, Pages 594-597

  Dubey, Lax ^a   Hesong, Z ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; DILTIAZEM; INTERLEUKIN 10;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFECT; FEMALE; HUMAN; MALE; PREVALENCE; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; ANTI-INFLAMMATORY AGENTS; CARDIOVASCULAR AGENTS; CASE-CONTROL STUDIES; DILTIAZEM; FEMALE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED;

EID: 33749189184     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2006.045302     Document Type: Article

References (29)

1. Foster V, Badimon L, Badimon J, et al. The pathogenisis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-50.
2. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50.
3. Davies MJ. Stability and instability: two faces of coronary atherosclerosis - the Paul Dudley White Lecture 1995. Circulation 1996;94:2013-20.
4. Liuzzo G, Kopecky SL, Frye RL, et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 1999;100:2135-9.
5. Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the council on atherosclerosis, American Heart Association. Circulation 1994;89:2462-78.
6. Smith DA, Irving SD, Sheldon J, et al. Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 2001;104:746-9.
7. Heeschen C, Dimmeler S, Hamm CW, et al. Serum level of the anti-inflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003;107:2109-14.
8. Gibson RS, Boden WE, Theroux P, et al. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double blind, randomized, multicenter trial. N Engl J Med 1986;315:423-9.
9. Uchida T, Kaneko N, Ogawa H, et al. Intravenous diltiazem versus isosorbide dinitrate for unstable angina: comparison of coronary angiographic morphology in the unstable and stabilized states. Coron Artery Dis 1994;5:773-7.
10. Yilmaz A, Reiss C, Tantawi O, et al. HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis. Atherosclerosis 2004;172:85-93.
11. Sharma R, Li D, Zeng Q, et al. Differentiation of dendritic cells in monocyte cultures isolated from patients with unstable angina. Int J Cardiol 2004;97:551-5.
12. Carreno BM, Collins M. The B7 family of ligands and its receptors; new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002;20:29-53.
13. Braunwald E. Unstable angina. A classification. Circulation 1989;80:410-14.
14. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol 1997;17:1859-67.
15. de Waal Malefyt R, Abrams RJ, Bennett B, et al. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
16. Florentine DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-95.
17. Alam SE, Nasser SS, Fernainy KE, et al. Cytokine imbalance in acute coronary syndrome. Curr Opin Pharmacol 2004;4:166-70.
18. Gobel EJ, Hautvast RWM, van Gilst WH, et al. Randomised, double-blind trial of intravenous diltiazem versus glyceryl trinitrate for unstable angina pectoris. Lancet 1995;346:1653-7.
19. Nicolau JC, Ramires JA, Maggioni AP, et al. Diltiazem improves left ventricular systolic function following acute myocardial infarction treated with streptokinase. The Calcium Antagonist in Reperfusion Study (CARES) Group. Am J Cardiol 1996;78:1049-52.
20. Gobel EJ, van Gilst WH, de Kam PJ, et al. Long-term follow-up after early intervention with intravenous diltiazem or intravenous nitroglycerin for unstable angina pectoris. Eur Heart J 1998;19:1208-13.
21. Theroux P, Gregoire J, Chin C, et al. Intravenous diltiazem in acute myocardial infarction. Diltiazem as adjunctive therapy to activase (DATA) trial. J Am Coll Cardiol 1998;32:620-8.
22. Pizzetti G, Mailhac A, Li Volsi L, et al. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction. Ital Heart J 2001;2:757-65.
23. Fansa I, Gol MK, Nisanoglu V, et al. Does diltiazem inhibit the inflammatory response cardiopulmonary bypass? Med Sci Monit 2003;9:48-54.
24. Szabo C, Hasko G, Nemeth ZH, et al. Calcium entry blockers increase interleukin-10 production in endotoxemia. Shock 1997;7:304-7.
25. D'Ambrosio A, Giacomini E, Camponeschi B, et al. Diltiazem modulates monokine production in human mixed lymphocyte culture. Transplantation 1998;65:1411.
26. D'Ambrosio A, Bachetoni A, Giacomini E, et al. Diltiazem down-regulates IL-12 production by human dendritic cells. Transplant Proc 2001;33:236.
27. Bachetoni A, D'Ambrosio A, Mariani P, et al. Diltiazem impairs maturation and functions of human dendritic cells. Hum Immunol 2002;63:524-33.
28. Ohtsuka T, Hamada M, Hiasa G, et al. Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy. J Am Coll Cardiol 2001;37:412-17.
29. Marx M, Weber M, Merkel F, et al. Additive effects of calcium antagonists on cyclosporin A-induced inhibition of T-cell proliferation. Nephrol Dial Transplant 1990;5:1038-44.